Abiopharma

🔍 Good Shad (Executive)

Company: IceCure Medical Ltd. (ICCM)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 131,483 shares of Ordinary Shares (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 136,698.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents (i) 131,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 219 ordinary shares, (iii) 2,021 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iv) 1,757 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (v) 1,218 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings in clauses (ii) through (v) have been adjusted to reflect the Issuer's 1-for-30 reverse share split.